UK’s Croda invests in personal care firm Cutitronics

UK-based sustainable ingredients developer Croda International has invested in Scotland-based Cutitronics.

Founded in 2014 at the University of Strathclyde, Cutitronics’ flagship product is handheld device CutiTron, which monitors skin health and delivers optimum skincare formulations.

Currently a prototype, the device is designed to analyse skin conditions and dispatch appropriate products.

Cutitronics founder and CEO Dr David Heath said: “Having validated CutiTron both technically and commercially, Croda’s support will allow us to bring our technology to market.”

The new investment is said to be part of Croda’s plans to find new technologies for delivering personalised skincare treatments.

Data captured by CutiTron will be used by the firm to develop new products.

Croda International Personal Care & North America president Sandra Breene said: “We have long known that digitalisation will play a key role in our growth strategy, and with this wealth of information, we can continue to develop innovative and sustainable ingredients, provide better formulation support, and share our knowledge with our customers as they strive to deliver the next generation of products to satisfy unmet market needs.”

Breene is set to join as a part time, non-executive officer on the Cutitronics board to serve through experience in the global personal care market and offer access to Croda’s formulation expertise.